C(OC([N:8]1[CH2:12][CH2:11][CH:10]([C:13]2[S:14][CH:15]=[C:16]([CH2:18][O:19][C:20]3[CH:25]=[CH:24][C:23]([N:26]4[CH:30]=[N:29][N:28]=[N:27]4)=[CH:22][CH:21]=3)[N:17]=2)[CH2:9]1)=O)(C)(C)C.[ClH:31]>ClCCl.CO.O1CCOCC1>[NH:8]1[CH2:12][CH2:11][CH:10]([C:13]2[S:14][CH:15]=[C:16]([CH2:18][O:19][C:20]3[CH:21]=[CH:22][C:23]([N:26]4[CH:30]=[N:29][N:28]=[N:27]4)=[CH:24][CH:25]=3)[N:17]=2)[CH2:9]1.[ClH:31]A solution of 3-[4-(4-Tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-pyrrolidine-1-carboxylic acid tert-butyl ester (from Example 102) (411 mg, 0.959 mmol) in dichloromethane (10 mL) and methanol (2 mL) were treated with 1 mL of 4N HCl in dioxane. The resulting solution was stirred at room temperature for 30 minutes. The solvents were removed in vacuo to afford the desired product as an HCl salt.
불러오는 중…